SEC Form 4 · accession 0000914190-16-000692
REGENERX BIOPHARMACEUTICALS INC · RGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allan L Goldstein
Director
Period of report
Apr 11, 2016
Accepted (ET)
Jul 15, 2016 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000707511
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 11, 2016 | G | 60,000 | $0.00 | D | 871,743 | D | |
| Common Stock | Apr 19, 2016 | G | 65,000 | $0.00 | D | 806,743 | D |
Table II — derivative securities
No Table II lines on this filing.